Article
EGFR expression variance in paired colorectal cancer primary and metastatic tumors.
Cancer biology & therapy - 1 Sept 2010
Yarom Nirit, Marginean Celia, Moyana Terence, Gorn-Hondermann Ivan, Birnboim H Chaim, Marginean Horia, Auer Rebecca C, Vickers Michael, Asmis Timothy R, Maroun Jean, Jonker Derek
Abstract excerpt
BACKGROUND: Previous studies indicate that drugs targeting the Epidermal Growth Factor Receptor (EGFR) signaling pathways can induce objective responses, prolong time to progression and improve survival of patients with metastatic colorectal cancer (mCRC). EGFR expression in the primary tumour may not predict response to these agents and data is conflicting regarding the correlation of EGFR expression in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
